Shanghai Biogene Biotechnology is a contract research organisation focused on protein interaction research. We build the libraries, run the screens and interpret the data that help research groups move from a gene list to a working interaction network.
What we do
Our work centres on yeast hybrid systems — two-hybrid, one-hybrid, three-hybrid, membrane two-hybrid and surface display — supported by CRISPR libraries, next-generation sequencing, proteomics and animal studies. Because library construction and screening sit in the same team, projects do not lose time or fidelity at the handover.
Technology
Our All-Direct library technology uses one-step homologous recombination rather than digestion and ligation. Libraries routinely exceed 1×10⁷ CFU primary capacity with average inserts above 1200 bp and a positive rate above 98%, and they support more than 500 independent screens.
Track record
We have delivered tens of thousands of libraries for institutes including the Chinese Academy of Sciences, Shanghai Jiao Tong University and Zhejiang University, across species from human and mouse to rice, wheat, Arabidopsis and insects.
Scan with WeChat